A prospective randomized multicentre study to compare Crinone 8% once daily versus other vaginal progesterone.
- Conditions
- uteal support in connnection with IVF/ICSI treatment.MedDRA version: 8.1Level: PTClassification code 10021926
- Registration Number
- EUCTR2005-001248-22-SE
- Lead Sponsor
- Fertilitetsklinikken Herlev Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- 2686
Inclusion Criteria
Women 18 to 40 years who are undergoing IVF/ICSI treatment and are willing to sign Informed Consent form.
Regular menstrual cycles 25 to 35 days.
Both ovaries present.
No more than 2 previous IVF attempts.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
More than 2 previous IVF attempts.
Known drug abuse.
Known allergies to the study medication.
No embryo transfer performed in the study cycle.
Previous participation in the study.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method